NEUWAY® Pharma

NEUWAY focuses on the pre-clinical development of innovative therapeutics for treatment of severe diseases with high medical need based on its proprietary Drug Delivery Platform so-called EnPC® (engineered protein capsules), particularly useful for the treatment of brain diseases.

EnPC® forms a virus-free protein capsid having a natural built-in on target property for delivering drugs. The capsids enables the encapsulation of different drug modalities (nucleic acids, antibodies, small molecules) that do not cross the physiological blood brain barrier (BBB). Combining EnPC® technology with a nucleic acid-based transcript therapy represents a unique approach for gene therapy.